TDAC
NASDAQ · N/A
Translational Development Ac
$10.88
+0.01 (+0.05%)
Open$10.86
Previous Close$10.88
Day High$10.90
Day Low$10.86
52W High$10.95
52W Low$10.41
Volume—
Avg Volume14.7K
Market Cap209.98M
P/E Ratio37.93
EPS$0.25
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 211.68M | 197.91M | 234.06M |
| Net Income | 7.59M | 7.31M | 8.97M |
| Profit Margin | 3.6% | 3.7% | 3.8% |
| EBITDA | 13.67M | 12.28M | 15.52M |
| Free Cash Flow | 6.88M | 4.06M | 6.97M |
| Rev Growth | +3.0% | +7.4% | -1.8% |
| Debt/Equity | 0.09 | 0.09 | 0.09 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.95 | -4.45% | — | 585.99M |
| PICS | Pics Nv | $7.39 | +6.18% | 4.1 | 961.54M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.15% | 50.1 | 652.61M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.61 | +0.00% | 21.3 | 168.92M |
| CEPF | Cantor Equity Partners-Cl A | $10.33 | +0.00% | 41.5 | 590.36M |